Department of Diabetes and Endocrinology, Saitama Medical Center, Saitama Medical University
Kawagoe, Saitama, 350-8550, Japan
NCT Number: NCT00892372
Control of body weight (BW) is important to prevent and manage type 2 diabetes. Regardless of the close association, little is understood about the precise relationship between BW and glycemic control, which might be of benefit for patients with type 2 diabetes. The researchers investigated the correlation between changes in BW and glycemic control in patients with type 2 diabetes treated with a diet therapy or pioglitazone.
Looking for future studies?
Notify Me32 year–76 year
All sexes
Observational
Kawagoe, Saitama, 350-8550, Japan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Saitama Medical University
Other
Relationship Between Changes in Body Weight and Glycohemoglobin Levels in Patients With Type 2 Diabetes Treated With Diet or Pioglitazone.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03926806
Body Weight, Diabetes Mellitus
View Trial DetailsNCT00128336
Behavior, Body Weight
Dunedin, New Zealand
View Trial DetailsNCT02173834
Body Weight, Diabetes Mellitus
Amsterdam, Netherlands
View Trial DetailsNCT00855166
Body Weight, Diabetes Mellitus
Blagoevgrad, Bulgaria
View Trial Details